Theranexus Logo

Theranexus | ALTHX - Profile, Filings, Stock Info & Investor Relations Data

Theranexus | ALTHX
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
France
Founded
2013
Theranexus (ALTHX)

About Theranexus

Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells.

Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease.

Market Presence

Worldwide

Headquarters

60 AVENUE ROCKEFELLER
69008, LYON
France

Company Video

Video thumbnail
Click to load video from YouTube

Theranexus (ALTHX)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Theranexus (ALTHX)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

Theranexus (ALTHX)
Stock & Investor Information

ISINs

FR0013286259

LEI

969500BFCV6IC7MFQP20

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View Theranexus on main exchange

Industry Classification